Clinical Trial Update: BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BLP25 Liposome Vaccine with Bevacizumab after chemo and radiation in newly diagnosed stage IIIA/IIIB non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BLP25 Liposome Vaccine (BLP25 liposome vaccine)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-03-26